Avm Biotechnology Inc
Clinical trials sponsored by Avm Biotechnology Inc, explained in plain language.
-
New hope for patients with Tough-to-Treat blood cancers
Disease control Recruiting nowThis study is testing a new drug called AVM0703 for people with advanced lymphoid cancers like lymphoma and leukemia. The main goals are to see if the drug is safe and if it can help shrink tumors. It is for patients whose cancer has come back or hasn't responded to other treatme…
Phase: PHASE1, PHASE2 • Sponsor: AVM Biotechnology Inc • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC
-
New cancer drug offered to patients through special access program
Disease control AVAILABLEThis program provides access to an experimental drug called AVM0703 for patients with various solid tumors and blood cancers. It is for people who may not have other treatment options. The drug aims to help the body's immune system fight cancer, and early reports show mostly mild…
Sponsor: AVM Biotechnology Inc • Aim: Disease control
Last updated Mar 25, 2026 14:07 UTC